The Invisible US Hispanic/Latino HIV Crisis: Addressing Gaps in the National Response.
AIDS Vaccines
Anti-Retroviral Agents
/ therapeutic use
Centers for Disease Control and Prevention, U.S.
/ organization & administration
Community Participation
/ methods
Female
HIV Infections
/ drug therapy
Health Behavior
/ ethnology
Health Services Accessibility
/ organization & administration
Hispanic or Latino
Homosexuality, Male
/ ethnology
Humans
Leadership
Male
Pre-Exposure Prophylaxis
/ methods
Public Health Surveillance
Risk-Taking
Social Stigma
Transgender Persons
United States
/ epidemiology
Journal
American journal of public health
ISSN: 1541-0048
Titre abrégé: Am J Public Health
Pays: United States
ID NLM: 1254074
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
pubmed:
15
11
2019
medline:
28
4
2020
entrez:
15
11
2019
Statut:
ppublish
Résumé
The federal government has proposed an end to HIV transmission in the United States by 2030. Although the United States has made substantial overall progress in the fight against HIV/AIDS, data released by the Centers for Disease Control and Prevention have raised concerns about widening, yet largely unrecognized, HIV infection disparities among Hispanic and Latino populations.This commentary identifies underlying drivers of increasing new HIV infections among Hispanics/Latinos, discusses existing national efforts to fight HIV in Hispanic/Latino communities, and points to gaps in the federal response. Consideration of the underlying drivers of increased HIV incidence among Hispanics/Latinos is warranted to achieve the administration's 2030 HIV/AIDS goals.Specifically, the proposed reinforcement of national efforts to end the US HIV epidemic must include focused investment in four priority areas: (1) HIV stigma reduction in Hispanic/Latino communities, (2) the availability and accessibility of HIV treatment of HIV-positive Hispanics/Latinos, (3) the development of behavioral interventions tailored to Hispanic/Latino populations, and (4) the engagement of Hispanic/Latino community leaders.
Identifiants
pubmed: 31725313
doi: 10.2105/AJPH.2019.305309
pmc: PMC6893335
doi:
Substances chimiques
AIDS Vaccines
0
Anti-Retroviral Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-31Subventions
Organisme : NIDA NIH HHS
ID : P30 DA011041
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH067127
Pays : United States
Références
J Pain Palliat Care Pharmacother. 2015 Jun;29(2):133-9
pubmed: 26095483
JAMA. 2019 Mar 5;321(9):844-845
pubmed: 30730529
Health Serv Res. 2018 Jun;53(3):1373-1386
pubmed: 28660697
Prev Med. 2018 Sep;114:64-71
pubmed: 29908762
N Engl J Med. 2019 May 23;380(21):1985-1987
pubmed: 31042822
AIDS Res Hum Retroviruses. 2015 Oct;31(10):973-80
pubmed: 26214548
J Behav Med. 2016 Jun;39(3):371-85
pubmed: 26831053
AIDS Behav. 2018 Aug;22(8):2500-2512
pubmed: 29948334
Am J Public Health. 2019 Jan;109(1):e1-e8
pubmed: 30496000
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150
pubmed: 30335734
AIDS Care. 2018 Jun;30(6):739-745
pubmed: 29063782